Cargando…
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
Ovarian Cancer (OVCA) is the most fatal gynecologic cancer and has a 5-year survival rate less than 45%. This is mainly due to late diagnosis and drug resistance. Overexpression of plasma gelsolin (pGSN) is key contributing factor to OVCA chemoresistance and immunosuppression. Gelsolin (GSN) is a mu...
Autores principales: | Onuma, Toshimichi, Asare-Werehene, Meshach, Yoshida, Yoshio, Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600545/ https://www.ncbi.nlm.nih.gov/pubmed/36291171 http://dx.doi.org/10.3390/cells11203305 |
Ejemplares similares
-
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
por: Asare-Werehene, Meshach, et al.
Publicado: (2022) -
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023) -
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
por: Chiu, Chen-Tzu, et al.
Publicado: (2020)